Skip to content

Clinical Study of Unani Formulation and Terbinafine in the Treatment of Ringworm

Clinical Study to Compare Safety & Efficacy of Unani Formulation , Ushq (Dorema ammoniacum) & Sirka ( Vinegar) With Terbinafine in Patients of Quba ( Dermatophytosis, Ringworm)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025361
Enrollment
60
Registered
2020-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Ushq and Sirka in equal quantity: Mode of application : Topical. Dose : QS for the area affected. Frequency : Twice daily. Duration of the protocol therapy : 60 days. Control Interventi

Sponsors

Central Council for Research in Unani Medicine New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Clinically diagnosed patients of Quba (confirmed on Direct Microscopy). -Irrespective of gender -Patients in the age group of 15 to 65 years. -Patients ready to participate in the study and ready to follow in instructions & voluntary written consent

Exclusion criteria

Exclusion criteria: -Patients below and above the age of 15 and 65 years respectively. -Patient suffering from concomitant diseases like psoriasis & Eczema. -Patient suffering from severe systemic and metabolic diseases. -Diabetic, HTN, COPD, Thyrotoxicosis etc and HIV patient. -Impaired organ functions -Patients with any trauma and accidents -Pregnant & Lactating Women. -Any of them not covered under inclusive criteria

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms of Quba(Rring worm, Dermatophytosis)Timepoint: 6-8 weeks

Secondary

MeasureTime frame
Haematological and biochemical assessment for safetyTimepoint: 6-8 weeks

Countries

India

Contacts

Public ContactNaquibul Islam

Regional Researcvh Institute of Unani Medicine

shameem.rather.sr@gmail.com7889584083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026